Bhatt Padmanabh P.
SEC insider (Form 3/4/5 filer). CIK 0001539215. Sr. VP of IP, CSO at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 62 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in ROCKVILLE, MD.
Companies Bhatt Padmanabh P. has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Officer, Sr. VP of IP, CSO
Bhatt Padmanabh P.
CIK: 0001539215
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (62 total)
- Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect2.5K shares- - Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.2K shares at avg. $46.57$54K - Jul 29, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
2.5K shares- - Mar 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect412 shares at avg. $50.48$21K - Mar 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect7.3K shares at avg. $39.40$286K - Mar 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect6.8K shares at avg. $49.55$339K - Mar 17, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect22.8K shares at avg. $39.40$896K - Mar 17, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect12.3K shares at avg. $36.75$450K - Mar 17, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect27.7K shares at avg. $49.95$1.4M - Mar 17, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect15K shares at avg. $38.60$579K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 2,500 | - | $0 | Direct |
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,158 | $46.57 | $53,928 | Direct |
| Jul 29, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 2,500 | - | - | Direct |
| Mar 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 412 | $50.48 | $20,798 | Direct |
| Mar 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 7,250 | $39.40 | $285,650 | Direct |
| Mar 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 6,838 | $49.55 | $338,823 | Direct |
| Mar 17, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 22,750 | $39.40 | $896,350 | Direct |
| Mar 17, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 12,250 | $36.75 | $450,188 | Direct |
| Mar 17, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 27,710 | $49.95 | $1,384,115 | Direct |
| Mar 17, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 15,000 | $38.60 | $579,000 | Direct |
1-10 of 62 transactions